Back

Our evolving understanding of TTR in the body

30 August 2025 (12:42 - 12:52)
Organised by: Logo
Congress Presentation Part of: Evolving practices in ATTR-CM: from science to patient care Cardiac Amyloidosis Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor M. Fontana (London, GB)
Presentation thumbnail
The start of a new era for science-driven patient care in ATTR-CM
Doctor M. Maurer (New York, US)
Presentation thumbnail
How have our treatment goals for ATTR-CM changed throughout the years?
Professor M. Fontana (London, GB)
Presentation thumbnail
Perceived challenges in patient care and how to overcome these in the clinic
Professor A. Yilmaz (Muenster, DE)
Presentation thumbnail
Q&A, panel discussion and close
Professor M. Fontana (London, GB) Doctor M. Maurer (New York, US) Professor A. Yilmaz (Muenster, DE) Professor T. Damy (Creteil, FR)

Access the full session

Session thumbnail
Evolving practices in ATTR-CM: from science to patient care

The Event

Event poster

ESC Congress 2025

30 August 2025 12:42 CET
You may be interested in
thumbnail
Congress Presentation
The role of TTR as a surrogate marker in treatment of ATTR-CM
2 September 2024
thumbnail
Webinar
New drugs in the treatment of amyloidosis
16 July 2025
thumbnail
Congress Presentation
Are triglycerides and triglyceride-rich lipoproteins still relevant?
25 August 2023
thumbnail
Congress Presentation
Targeting titin in dilated cardiomyopathy
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources